Table 1.
Characteristic | N | Overall N = 234* |
Survived N = 186* |
Dead N = 48* |
P Value† |
---|---|---|---|---|---|
Sex | 234 | .063 | |||
Female | 64 (27%) | 56 (30%) | 8 (17%) | ||
Male | 170 (73%) | 130 (70%) | 40 (83%) | ||
Age | 234 | 60 (54, 66) | 59 (53, 66) | 63 (58, 68) | .033 |
Ethnicity | 234 | .9 | |||
Not disclosed | 6 (2.6%) | 5 (2.7%) | 1 (2.1%) | ||
Asian | 3 (1.3%) | 3 (1.6%) | 0 (0%) | ||
Black | 13 (5.6%) | 12 (6.5%) | 1 (2.1%) | ||
Mixed race | 66 (28%) | 52 (28%) | 14 (29%) | ||
White | 146 (62%) | 114 (61%) | 32 (67%) | ||
Years since LTX | 232 | 2.6 (1.0, 6.6) | 3.1 (1.1, 6.6) | 1.6 (0.9, 5.9) | .11 |
Diabetes | 234 | 110 (47%) | 89 (48%) | 21 (44%) | .6 |
Dyslipidemia | 234 | 7 (3.0%) | 5 (2.7%) | 2 (4.2%) | .6 |
Chronic Kidney Disease | 234 | 29 (12%) | 21 (11%) | 8 (17%) | .3 |
Hypertension | 234 | 111 (47%) | 88 (47%) | 23 (48%) | > .9 |
Cardiovascular disease | 234 | 22 (9.4%) | 19 (10%) | 3 (6.2%) | .6 |
Obesity | 211 | 55 (26%) | 37 (22%) | 18 (44%) | .004 |
Fever | 234 | 121 (52%) | 94 (51%) | 27 (56%) | .5 |
Nausea | 234 | 13 (5.6%) | 9 (4.8%) | 4 (8.3%) | .3 |
Odynophagia | 234 | 6 (2.6%) | 5 (2.7%) | 1 (2.1%) | > .9 |
Cough | 234 | 115 (49%) | 93 (50%) | 22 (46%) | .6 |
Choryza | 234 | 36 (15%) | 32 (17%) | 4 (8.3%) | .13 |
Dyspnea | 234 | 77 (33%) | 48 (26%) | 29 (60%) | < .001 |
Abdominal pain | 234 | 5 (2.1%) | 5 (2.7%) | 0 (0%) | .6 |
Diarrhea | 234 | 43 (18%) | 35 (19%) | 8 (17%) | .7 |
Lost sense of smell | 234 | 26 (11%) | 25 (13%) | 1 (2.1%) | .026 |
Assymptomatic | 234 | 12 (5.1%) | 11 (5.9%) | 1 (2.1%) | .5 |
Disease wave | 229 | .12 | |||
First | 111 (48%) | 84 (46%) | 27 (59%) | ||
Second | 118 (52%) | 99 (54%) | 19 (41%) | ||
Hospitalized | 234 | 146 (62%) | 98 (53%) | 48 (100%) | < .001 |
ICU | 234 | 64 (27%) | 23 (12%) | 41 (85%) | < .001 |
Mechanical Ventilation | 234 | 44 (19%) | 5 (2.7%) | 39 (81%) | < .001 |
Mechanical ventilation Length | 45 | 12 (5, 20) | 8 (5, 12) | 13 (4, 20) | .3 |
Need for pronation | 45 | 19 (40%) | 3 (43%) | 16 (40%) | > .9 |
Need for renal replacement therapy | 234 | 36 (15%) | 9 (4.8%) | 27 (56%) | < .001 |
Follow up time (d) | 221 | 106 (40, 273) | 162 (73, 297) | 22 (10, 35) | < .001 |
CXR alterations | 33 | 23 (70%) | 11 (58%) | 12 (86%) | .13 |
Chest CT alterations | 143 | 128 (90%) | 88 (85%) | 40 (100%) | .012 |
Descriptive variables displayed as “count (percentage)” and continuous variables displayed as “median (IQR).”
n (%); Median (IQR).
CT = computed tomography; CXR = Chest X-Ray; ICU = INtensive Care Unit; LTX = Liver transplantation.
Pearson's χ2 test; Wilcoxon rank sum test; Fisher's exact test.